(Q30834858)

27 June 2017

1 reference

title

Generating improved single-chain Fv molecules for tumor targeting (English)

1 reference

27 June 2017

Adams GP

1

1 reference

PubMed ID

10648942

27 June 2017

Schier R

series ordinal

2

1 reference

27 June 2017

1 December 1999

1 reference

Journal of Immunological Methods

27 June 2017

1 reference

27 June 2017

231

1 reference

27 June 2017

249-260

1 reference

27 June 2017

1-2

1 reference

Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2/neu

27 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Antibody engineering by parsimonious mutagenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Single-chain antigen-binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Permselectivity of the glomerular capillary wall to macromolecules. II. Experimental studies in rats using neutral dextran

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Making antibody fragments using phage display libraries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

In vivo tumor targeting of a recombinant single-chain antigen-binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Construction and evolution of antibody-phage libraries by DNA shuffling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Selection and application of human single chain Fv antibody fragments from a semi-synthetic phage antibody display library with designed CDR3 regions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Rapid selection of cell subpopulation-specific human monoclonal antibodies from a synthetic phage antibody library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Clinical significance of IgG Fc receptors and Fc gamma R-directed immunotherapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

FcRn: the MHC class I-related receptor that is more than an IgG transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Isolation of high affinity human antibodies directly from large synthetic repertoires.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

In vitro selection and evolution of functional proteins by using ribosome display

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Ribosome display efficiently selects and evolves high-affinity antibodies in vitro from immune libraries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Selection of phage antibodies by binding affinity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

"Diabodies": small bivalent and bispecific antibody fragments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

By-passing immunisation. Human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Triabodies: single chain Fv fragments without a linker form trivalent trimers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Affinity maturation of recombinant antibodies using E. coli mutator cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Antigen specificity and tumour targeting efficiency of a human carcinoembryonic antigen-specific scFv and affinity-matured derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

The next frontier of molecular medicine: delivery of therapeutics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Orientation of antigen binding sites in dimeric and trimeric single chain Fv antibody fragments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Mimicking somatic hypermutation: affinity maturation of antibodies displayed on bacteriophage using a bacterial mutator strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Renal filtration, transport, and metabolism of low-molecular-weight proteins: A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

By-passing immunization. Human antibodies from V-gene libraries displayed on phage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

By-passing immunization: building high affinity human antibodies by chain shuffling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

A dimeric bispecific miniantibody combines two specificities with avidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Generation of a panel of related human scFv antibodies with high affinities for human CEA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

A model system for detection and isolation of a tumor cell surface antigen using antibody phage display

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Hierarchical affinity maturation of a phage library derived antibody for the selective removal of cytomegalovirus from plasma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Isoelectric point of albumin: Effect on renal handling of albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

A phage display approach for rapid antibody humanization: designed combinatorial V gene libraries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

In vitro and in vivo characterization of a human anti-c-erbB-2 single-chain Fv isolated from a filamentous phage antibody library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Identification of functional and structural amino-acid residues by parsimonious mutagenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Rapid evolution of a protein in vitro by DNA shuffling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Efficient selection of scFv antibody phage by adsorption to in situ expressed antigens in tissue sections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

VH shuffling can be used to convert an Fv fragment of anti-hen egg lysozyme specificity to one that recognizes a T cell receptor V alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

The pharmacology of monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

Making antibodies by phage display technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900161-1

10.1016/S0022-1759(99)00161-1

7 January 2021

Identifiers

DOI

1 reference

27 June 2017

1 reference

PubMed ID

10648942